JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4451
OneWater Marine
ONEW
$164M
| $69K | ﹤0.01% |
+8,978
| New | +$105K |
2020 Q1
0 quarters
|
|
|
CALA
4452
DELISTED
Calithera Biosciences, Inc
CALA
| $69K | ﹤0.01% |
774
-27
| -3% | -$3.22K |
2017 Q4
9 quarters
|
|
|
BXG
4453
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
| $69K | ﹤0.01% |
12,045
-39,496
| -77% | -$317K |
2018 Q3
6 quarters
|
|
4454
Empire State Realty Series ES
ESBA
$1.08B
| $68K | ﹤0.01% |
+7,619
| New | +$92.9K |
2020 Q1
0 quarters
|
|
4455
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.88B
| $68K | ﹤0.01% |
10,665
-1,650
| -13% | -$13.3K |
2019 Q3
2 quarters
|
|
4456
Rayonier Advanced Materials
RYAM
$482M
| $68K | ﹤0.01% |
63,280
-97,468
| -61% | -$254K |
2015 Q3
18 quarters
|
|
|
BPY
4457
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $68K | ﹤0.01% |
8,495
-28,732
| -77% | -$465K |
2015 Q4
17 quarters
|
|
4458
PUT
Evolus
EOLS
$472M
| $67K | ﹤0.01% |
16,100
-62,200
| -79% | -$527K |
2019 Q1
4 quarters
|
|
4459
iShares Convertible Bond ETF
ICVT
$8.08B
| $67K | ﹤0.01% |
1,235
| – | – |
2017 Q4
9 quarters
|
|
4460
iShares Russell Top 200 Growth ETF
IWY
$16.4B
| $67K | ﹤0.01% |
799
+191
| +31% | +$18.2K |
2019 Q3
2 quarters
|
|
4461
Kura Sushi USA
KRUS
$505M
| $67K | ﹤0.01% |
5,627
-961
| -15% | -$18.9K |
2019 Q3
2 quarters
|
|
4462
Ocular Therapeutix
OCUL
$1.53B
| $67K | ﹤0.01% |
13,494
-99
| -0.7% | -$489 |
2017 Q1
12 quarters
|
|
|
LGF.B
4463
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $67K | ﹤0.01% |
12,067
-178,485
| -94% | -$1.49M |
2016 Q4
13 quarters
|
|
4464
Arlo Technologies
ARLO
$1.38B
| $66K | ﹤0.01% |
27,237
+3,000
| +12% | +$10.4K |
2018 Q3
6 quarters
|
|
4465
Capital Southwest
CSWC
$1.5B
| $66K | ﹤0.01% |
5,763
+1,288
| +29% | +$23.3K |
2016 Q1
16 quarters
|
|
|
LNAI
4466
Lunai Bioworks
LNAI
$5.89M
| $66K | ﹤0.01% |
277
+37
| +15% | +$11K |
2019 Q1
4 quarters
|
|
4467
WhiteHorse Finance
WHF
$150M
| $66K | ﹤0.01% |
9,270
-47,712
| -84% | -$595K |
2018 Q4
5 quarters
|
|
4468
Adicet Bio
ACET
$60.8M
| $65K | ﹤0.01% |
561
-54
| -9% | -$8.02K |
2018 Q1
8 quarters
|
|
4469
ADMA Biologics
ADMA
$2.18B
| $65K | ﹤0.01% |
22,636
+6,136
| +37% | +$21.2K |
2018 Q1
8 quarters
|
|
4470
Comp X International
CIX
$461M
| $65K | ﹤0.01% |
4,266
+622
| +17% | +$9.28K |
2016 Q4
13 quarters
|
|
4471
Mayville Engineering Co
MEC
$419M
| $65K | ﹤0.01% |
10,667
+2,460
| +30% | +$18.5K |
2019 Q2
3 quarters
|
|
4472
Napco Security Technologies
NSSC
$1.29B
| $65K | ﹤0.01% |
8,478
+6
| +0.1% | +$71 |
2017 Q4
9 quarters
|
|
4473
Organogenesis Holdings
ORGO
$171M
| $65K | ﹤0.01% |
20,028
+5,852
| +41% | +$25K |
2019 Q1
4 quarters
|
|
4474
Invesco CEF Income Composite ETF
PCEF
$776M
| $65K | ﹤0.01% |
3,711
+3,488
| +1,564% | +$75.5K |
2015 Q4
17 quarters
|
|
|
PSTL
4475
Postal Realty Trust
PSTL
$686M
| $65K | ﹤0.01% |
4,100
+2,100
| +105% | +$32.7K |
2019 Q4
1 quarter
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.